Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010−2011
Kashmira A. Date
, Andrea Vicari, Terri B. Hyde, Eric D. Mintz, M. Carolina Danovaro-Holliday, Ariel Henry, Jordan W. Tappero, Thierry H. Roels, Joseph Abrams, Brenton T. Burkholder, Cuauhtémoc Ruiz-Matus, Jon Andrus, and Vance Dietz
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K.A. Date, T.B. Hyde, E. Mintz, A. Henry, J.W. Tappero, T.H. Roels, J. Abrams, B.T. Burkholder, V. Dietz); Pan American Health Organization, Washington DC, USA (A. Vicari, M.C. Danovaro-Holliday, C. Ruiz-Matus, J. Andrus); Ministère de la Santé Publique et de la Population, Port-Au-Prince, Haiti (A. Henry)
Figure 2. Events and actions related to considerations for cholera vaccination, Haiti, October 2010–April 2011. The full epicurve after January 18 is shown for reference only. Events and discussions regarding vaccination or other events after that date are not depicted. UN, United Nations; CFR, case-fatality rate; CDC, Centers for Disease Control and Prevention; MSPP, Haiti Ministère de Santé Publique et de la Population; PAHO, Pan American Health Organization.
Page created: October 27, 2011
Page updated: October 27, 2011
Page reviewed: October 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.